Cogent Biosciences: Bezuclastinib's Potential In Treating Gastrointestinal Stromal Tumors Seeking Alpha, 28 Feb 2023 Follow Summary Cogent Biosciences is a biotechnology company focused on developing solutions for complex medical conditions…